Oligomerization of Dopamine and Serotonin Receptors
暂无分享,去创建一个
B. O'dowd | S. George | Tuan V. Nguyen | George Varghese | Tuan Nguyen | Susan R George | Samuel P. Lee | Samuel P Lee | Zhidong Xie | Brian F O'Dowd | G. Varghese | Zhidong Xie
[1] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[2] H. Akil,et al. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.
[3] M. Caron,et al. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. , 1993, Biochemistry.
[4] H. W. Harris,et al. Disulfide Bonds in the Extracellular Calcium-Polyvalent Cation-sensing Receptor Correlate with Dimer Formation and Its Response to Divalent Cations in Vitro * , 1998, The Journal of Biological Chemistry.
[5] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[6] G. Köhr,et al. Role of heteromer formation in GABAB receptor function. , 1999, Science.
[7] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[8] J. Morrison,et al. Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[9] L. Gama,et al. Dimerization of the Calcium-sensing Receptor Occurs within the Extracellular Domain and Is Eliminated by Cys → Ser Mutations at Cys101 and Cys236 * , 1999, The Journal of Biological Chemistry.
[10] R. Rozmahel,et al. Characterization of the human 5-hydroxytryptamine1B receptor. , 1992, The Journal of biological chemistry.
[11] Jilly F. Evans,et al. Identification of a GABAB Receptor Subunit, gb2, Required for Functional GABAB Receptor Activity* , 1999, The Journal of Biological Chemistry.
[12] B. Kobilka,et al. Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation* , 1997, The Journal of Biological Chemistry.
[13] Kenneth A. Jones,et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.
[14] L. Uphouse. Multiple Serotonin Receptors: Too Many, Not Enough, or Just the Right Number? , 1997, Neuroscience & Biobehavioral Reviews.
[15] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[16] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[17] B. O'dowd,et al. Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.
[18] T. Gudermann,et al. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. , 1997, Molecular endocrinology.
[19] P. Seeman,et al. A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.
[20] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[21] S. R. Nash,et al. Dopamine receptors: from structure to function. , 1998, Physiological reviews.
[22] P. Bonaventure,et al. Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function , 1997, Neuroscience.
[23] C. Bergson,et al. On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain. , 1994, The Journal of biological chemistry.
[24] Bruno Giros,et al. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.
[25] F. Marshall,et al. GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.
[26] P. Seeman,et al. Glycoprotein nature of D2 dopamine receptors , 1988, FEBS letters.
[27] J. Wess,et al. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.
[28] B. O'dowd,et al. The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. , 2000, Brain research. Molecular brain research.
[29] A. Spiegel,et al. Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: effects on cell surface expression, dimerization and signal transduction , 1998, FEBS letters.
[30] B. Borowsky,et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. , 1998, Nature.
[31] C. Reynolds,et al. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.
[32] J. Wess,et al. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.
[33] P. Seeman,et al. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. , 1997, Endocrinology.
[34] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[35] C. Romano,et al. Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.
[36] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[37] J. Stevens,et al. Agonist-induced desensitization of dopamine D1 receptor-stimulated adenylyl cyclase activity is temporally and biochemically separated from D1 receptor internalization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[39] Kuan-Teh Jeang,et al. Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.
[40] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[41] V C Emery,et al. Baculovirus expression vectors. , 1991, Methods in molecular biology.
[42] T. Ezashi,et al. Suppression of Prostaglandin E Receptor Signaling by the Variant Form of EP1 Subtype* , 1996, The Journal of Biological Chemistry.
[43] M. Caron,et al. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. , 1994, European journal of pharmacology.